Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps
While the world rushed to develop treatments for COVID-19, some turned hopefully to drug repurposing (drug repositioning). However, little study has addressed issues of drug repurposing in emergency situations from a broader perspective, taking into account the social and ethical ramifications. When...
| Authors: | ; ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Published: |
2021
|
| In: |
Cambridge quarterly of healthcare ethics
Year: 2021, Volume: 30, Issue: 1, Pages: 51-58 |
| Further subjects: | B
drug repurposing
B Covid-19 B resource distribution B drug repositioning |
| Online Access: |
Volltext (kostenfrei) Volltext (kostenfrei) |
MARC
| LEADER | 00000naa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 182797219X | ||
| 003 | DE-627 | ||
| 005 | 20221220052640.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221220s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S0963180120000481 |2 doi | |
| 035 | |a (DE-627)182797219X | ||
| 035 | |a (DE-599)KXP182797219X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Ino, Hiroyasu |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a While the world rushed to develop treatments for COVID-19, some turned hopefully to drug repurposing (drug repositioning). However, little study has addressed issues of drug repurposing in emergency situations from a broader perspective, taking into account the social and ethical ramifications. When drug repurposing is employed in emergency situations, the fairness of resource distribution becomes an issue that requires careful ethical consideration.This paper examines the drug repurposing in emergency situations focusing on the fairness using Japanese cases. Ethical issues under these circumstances addressed by the authors include: maintaining the evidence level, integrity of clinical research ethics, and voluntary consent by original indication patients. In order to address these issues, they argue that rapid accumulation of ethically and scientifically valid evidence is required, as is obtaining information on resource quantity. | ||
| 601 | |a COVID-19 | ||
| 650 | 4 | |a resource distribution | |
| 650 | 4 | |a drug repositioning | |
| 650 | 4 | |a drug repurposing | |
| 650 | 4 | |a Covid-19 | |
| 700 | 1 | |a Nakazawa, Eisuke |e VerfasserIn |4 aut | |
| 700 | 1 | |a Akabayashi, Akira |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cambridge quarterly of healthcare ethics |d Cambridge : Cambridge Univ. Press, 1992 |g 30(2021), 1, Seite 51-58 |h Online-Ressource |w (DE-627)306655039 |w (DE-600)1499985-7 |w (DE-576)081985010 |x 1469-2147 |7 nnas |
| 773 | 1 | 8 | |g volume:30 |g year:2021 |g number:1 |g pages:51-58 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/S0963180120000481 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/drug-repurposing-for-covid19-ethical-considerations-and-roadmaps/EA767740F3D7656330DB621F96FAAEE0 |x Verlag |z kostenfrei |3 Volltext |
| 935 | |a mteo | ||
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4235377108 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 182797219X | ||
| LOK | |0 005 20221220052640 | ||
| LOK | |0 008 221220||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2022-12-06#BE5C161C86BD9929DB07C862806CB0E8505B6F73 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||
